114 related articles for article (PubMed ID: 29152105)
1. Necdin modulates leukemia-initiating cell quiescence and chemotherapy response.
Yao C; Kobayashi M; Chen S; Nabinger SC; Gao R; Liu SZ; Asai T; Liu Y
Oncotarget; 2017 Oct; 8(50):87607-87622. PubMed ID: 29152105
[TBL] [Abstract][Full Text] [Related]
2. Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells.
Asai T; Liu Y; Di Giandomenico S; Bae N; Ndiaye-Lobry D; Deblasio A; Menendez S; Antipin Y; Reva B; Wevrick R; Nimer SD
Blood; 2012 Aug; 120(8):1601-12. PubMed ID: 22776820
[TBL] [Abstract][Full Text] [Related]
3. Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy.
Haladyna JN; Pastuer T; Riedel SS; Perraud AL; Bernt KM
Exp Hematol; 2016 Jul; 44(7):596-602.e3. PubMed ID: 27033163
[TBL] [Abstract][Full Text] [Related]
4. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
[TBL] [Abstract][Full Text] [Related]
5. CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling.
Fang X; Chen C; Xia F; Yu Z; Zhang Y; Zhang F; Gu H; Wan J; Zhang X; Weng W; Zhang CC; Chen GQ; Liang A; Xie L; Zheng J
J Hematol Oncol; 2016 Nov; 9(1):124. PubMed ID: 27855694
[TBL] [Abstract][Full Text] [Related]
6. Phosphoinositide-dependent kinase 1 regulates leukemia stem cell maintenance in MLL-AF9-induced murine acute myeloid leukemia.
Hu T; Li C; Zhang Y; Wang L; Peng L; Cheng H; Wang W; Chu Y; Xu M; Cheng T; Yuan W
Biochem Biophys Res Commun; 2015 Apr; 459(4):692-8. PubMed ID: 25769952
[TBL] [Abstract][Full Text] [Related]
7. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia.
Matsuo H; Iijima-Yamashita Y; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):41-46. PubMed ID: 29067751
[TBL] [Abstract][Full Text] [Related]
9. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.
Liu Q; Chen L; Atkinson JM; Claxton DF; Wang HG
Cell Death Dis; 2016 Sep; 7(9):e2361. PubMed ID: 27607576
[TBL] [Abstract][Full Text] [Related]
10. Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells.
Eriksson M; Peña-Martínez P; Ramakrishnan R; Chapellier M; Högberg C; Glowacki G; Orsmark-Pietras C; Velasco-Hernández T; Lazarević VL; Juliusson G; Cammenga J; Mulloy JC; Richter J; Fioretos T; Ebert BL; Järås M
Blood Adv; 2017 Oct; 1(23):2046-2057. PubMed ID: 29296851
[TBL] [Abstract][Full Text] [Related]
11. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation.
Barone C; Orsenigo R; Cazzola A; D'Errico E; Patelli A; Quattrini G; Vergani B; Bombelli S; De Marco S; D'Orlando C; Bianchi C; Leone BE; Meneveri R; Biondi A; Cazzaniga G; Rabbitts TH; Brunelli S; Azzoni E
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509285
[TBL] [Abstract][Full Text] [Related]
13. ChREBP promotes the differentiation of leukemia-initiating cells to inhibit leukemogenesis through the TXNIP/RUNX1 pathways.
Zeng H; Gu H; Chen C; Li M; Xia F; Xie L; Liu X; Zhang F; Tong X; Wang J; Yu Z; Zheng J
Oncotarget; 2016 Jun; 7(25):38347-38358. PubMed ID: 27224916
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic significance of detecting MLL-AF9 fusion gene expression in patients with acute myeloid leukemia by real-time fluorescence quantitative PCR].
Huang S; Yang H; Gao L; Dou LP; Xu YY; Wang N; Wang LL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1435-40. PubMed ID: 24370025
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of leukemia-initiating cells is regulated by the CDK inhibitor Inca1.
Bäumer N; Bäumer S; Berkenfeld F; Stehling M; Köhler G; Berdel WE; Müller-Tidow C; Tschanter P
PLoS One; 2014; 9(12):e115578. PubMed ID: 25525809
[TBL] [Abstract][Full Text] [Related]
16. MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.
Stavropoulou V; Kaspar S; Brault L; Sanders MA; Juge S; Morettini S; Tzankov A; Iacovino M; Lau IJ; Milne TA; Royo H; Kyba M; Valk PJM; Peters AHFM; Schwaller J
Cancer Cell; 2016 Jul; 30(1):43-58. PubMed ID: 27344946
[TBL] [Abstract][Full Text] [Related]
17. Role of the bone marrow vascular niche in chemotherapy for MLL-AF9-induced acute myeloid leukemia.
Xu C; Lu T; Lv X; Cheng T; Cheng H
Blood Sci; 2023 Apr; 5(2):92-100. PubMed ID: 37228781
[TBL] [Abstract][Full Text] [Related]
18. The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL) Rearrangements.
Yang H; Huang S; Zhu CY; Gao L; Zhu HY; Lv N; Jing Y; Yu L
Med Sci Monit; 2016 Jul; 22():2315-23. PubMed ID: 27373985
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of the retrovirus-mediated murine model with MLL-AF9 leukemia].
Xu SM; Yang Y; Zhou M; Zhao XJ; Qin Y; Zhang PL; Yuan RF; Zhou JF; Fang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1126-32. PubMed ID: 24156419
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of Eed impedes MLL-AF9-mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model.
Danis E; Yamauchi T; Echanique K; Haladyna J; Kalkur R; Riedel S; Zhu N; Xie H; Bernt KM; Orkin SH; Armstrong SA; Neff T
Exp Hematol; 2015 Nov; 43(11):930-935.e6. PubMed ID: 26118502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
